Cleared Traditional

K973456 - SPIROBANK PORTABLE PC BASED SPIROMETER

K973456 is an FDA 510(k) clearance for SPIROBANK PORTABLE PC BASED SPIROMETER, manufactured by Futuremed America, Inc.. The device is a Class 2 Anesthesiology device with product code BZG cleared through the Traditional 510(k) pathway after a 314-day FDA review.

K973456 · Futuremed America, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1998
Decision
314d
Days
Class 2
Risk

K973456 is an FDA 510(k) clearance for the SPIROBANK PORTABLE PC BASED SPIROMETER. Classified as Spirometer, Diagnostic (product code BZG), Class II - Special Controls.

Submitted by Futuremed America, Inc. (Granada Hills, US). The FDA issued a Cleared decision on July 22, 1998 after a review of 314 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1840 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Futuremed America, Inc. devices

FDA 510(k) Submission Details - K973456

510(k) Number K973456 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 11, 1997
Decision Date July 22, 1998
Days to Decision 314 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
174d slower than avg
Panel avg: 140d · This submission: 314d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BZG Device Classification - Class 2, Special Controls

Product Code BZG Spirometer, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1840
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZG Spirometer, Diagnostic

All 69
Devices cleared under the same product code (BZG) and FDA review panel - the closest regulatory comparables to K973456.
SPIROVIT, MODEL SP-250
K984031 · Schiller AG · Apr 1999
CAIRD TECHNOLOGY SPIROMETER
K971336 · Caird Technology · Dec 1998
SPIROCARD
K973138 · Qrs Diagnostic, LLC · Oct 1998
SPIROMETER MODEL NPB-500
K980441 · Nellcor Puritan Bennett, Inc. · Apr 1998
MICRODL DIARYCARD SPIROMETER
K965042 · Micro Direct, Inc. · Jun 1997
ASTHMA MONITOR
K960078 · Erich Jaeger, Inc. · Sep 1996